AAAAAA
Results:
1-21
|
Results: 21
Authors:
Grossmann, ME
Davila, E
Celis, E
Citation: Me. Grossmann et al., Avoiding tolerance against prostatic antigens with subdominant peptide epitopes, J IMMUNOTH, 24(3), 2001, pp. 237-241
Expression, specificity and immunotherapy potential of prostate-associatedgenes in murine cell lines
Authors:
Grossmann, ME
Wood, M
Celis, E
Citation: Me. Grossmann et al., Expression, specificity and immunotherapy potential of prostate-associatedgenes in murine cell lines, WORLD J URO, 19(5), 2001, pp. 365-370
Authors:
Keogh, E
Fikes, J
Southwood, S
Celis, E
Chesnut, R
Sette, A
Citation: E. Keogh et al., Identification of new epitopes from four different tumor-associated antigens: Recognition of naturally processed epitopes correlates with HLA-A0201-binding affinity, J IMMUNOL, 167(2), 2001, pp. 787-796
Authors:
Lu, J
Wettstein, PJ
Higashimoto, Y
Appella, E
Celis, E
Citation: J. Lu et al., TAP-Independent presentation of CTL epitopes by trojan antigens, J IMMUNOL, 166(12), 2001, pp. 7063-7071
Authors:
Kobayashi, H
Lu, J
Celis, E
Citation: H. Kobayashi et al., Identification of helper T-cell epitopes that encompass or lie proximal tocytotoxic T-cell epitopes in the gp100 melanoma tumor antigen, CANCER RES, 61(20), 2001, pp. 7577-7584
Authors:
Kobayashi, H
Song, YS
Hoon, DSB
Appella, E
Celis, E
Citation: H. Kobayashi et al., Tumor-reactive T helper lymphocytes recognize a promiscuous MAGE-A3 epitope presented by various major histocompatibility complex class II alleles, CANCER RES, 61(12), 2001, pp. 4773-4778
Authors:
Ressing, ME
van Driel, WJ
Brandt, RMP
Kenter, GG
de Jong, JH
Bauknecht, T
Fleuren, GJ
Hoogerhout, P
Offringa, R
Sette, A
Celis, E
Grey, H
Trimbos, BJ
Kast, WM
Melief, CJM
Citation: Me. Ressing et al., Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma, J IMMUNOTH, 23(2), 2000, pp. 255-266
Authors:
Cho, S
Mehra, V
Thoma-Uszynski, S
Stenger, S
Serbina, N
Mazzaccaro, RJ
Flynn, JL
Barnes, PF
Southwood, S
Celis, E
Bloom, BR
Modlin, RL
Sette, A
Citation: S. Cho et al., Antimicrobial activity of MHC class I-restricted CD8+T cells in human tuberculosis, P NAS US, 97(22), 2000, pp. 12210-12215
Authors:
Davila, E
Celis, E
Citation: E. Davila et E. Celis, Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity, J IMMUNOL, 165(1), 2000, pp. 539-547
Authors:
Reynolds, SR
Celis, E
Sette, A
Oratz, R
Shapiro, RL
Johnston, D
Fotino, M
Bystryn, JC
Citation: Sr. Reynolds et al., Identification of HLA-A03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis, J IMMUNOL M, 244(1-2), 2000, pp. 59-67
Authors:
Lu, J
Celis, E
Citation: J. Lu et E. Celis, Use of two predictive algorithms of the World Wide Web for the identification of tumor-reactive T-cell epitopes, CANCER RES, 60(18), 2000, pp. 5223-5227
Authors:
Kobayashi, H
Wood, M
Song, YS
Appella, E
Celis, E
Citation: H. Kobayashi et al., Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen, CANCER RES, 60(18), 2000, pp. 5228-5236
Authors:
Vanaja, DK
Grossmann, ME
Celis, E
Young, CYF
Citation: Dk. Vanaja et al., Tumor prevention and antitumor immunity with heat shock protein 70 inducedby 15-deoxy-Delta(12,14)-prostaglandin J(2) in transgenic adenocarcinoma of mouse prostate cells, CANCER RES, 60(17), 2000, pp. 4714-4718
Authors:
Celis, E
Citation: E. Celis, Identification and selection of T-cell epitopes derived from tumor-associated antigens for the development of immunotherapy for cancer, MED INTEL U, 24, 2000, pp. 1-16
Authors:
Weber, JS
Hua, FL
Spears, L
Marty, V
Kuniyoshi, C
Celis, E
Citation: Js. Weber et al., A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma, J IMMUNOTH, 22(5), 1999, pp. 431-440
Authors:
Tahara, K
Takesako, K
Sette, A
Celis, E
Kitano, S
Akiyoshi, T
Citation: K. Tahara et al., Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes, CLIN CANC R, 5(8), 1999, pp. 2236-2241
Authors:
Yang, RC
Salazar-Onfray, F
Charo, J
Malmberg, KJ
Evrin, K
Maes, H
Kono, K
Hising, C
Petersson, M
Larsson, O
Lan, L
Appella, E
Sette, A
Celis, E
Kiessling, R
Citation: Rc. Yang et al., Identification of new HER2/neu-derived peptide epitopes that can elicit specific CTL against autologous and allogeneic carcinomas and melanomas, J IMMUNOL, 163(2), 1999, pp. 1037-1044
Authors:
Livingston, BD
Alexander, J
Crimi, C
Oseroff, C
Celis, E
Daly, K
Guidotti, LG
Chisari, FV
Fikes, J
Chesnut, RW
Sette, A
Citation: Bd. Livingston et al., Altered helper T lymphocyte function associated with chronic hepatitis B virus infection and its role in response to therapeutic vaccination in humans, J IMMUNOL, 162(5), 1999, pp. 3088-3095
Authors:
Kawashima, I
Tsai, V
Southwood, S
Takesako, K
Sette, A
Celis, E
Citation: I. Kawashima et al., Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization withpeptide-pulsed dendritic cells, CANCER RES, 59(2), 1999, pp. 431-435
Authors:
Kundu, SK
Dupuis, M
Sette, A
Celis, E
Dorner, F
Eibl, M
Merigan, TC
Citation: Sk. Kundu et al., Role of preimmunization virus sequences in cellular immunity in HIV-infected patients during HIV type 1 MN recombinant gp160 immunization, AIDS RES H, 14(18), 1998, pp. 1669-1678
Authors:
Reynolds, SR
Celis, E
Sette, A
Oratz, R
Shapiro, RL
Johnston, D
Fotino, M
Bystryn, JC
Citation: Sr. Reynolds et al., HLA-independent heterogeneity of CD8(+) T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients, J IMMUNOL, 161(12), 1998, pp. 6970-6976
Risultati:
1-21
|